Cargando…

The lung–gut axis during viral respiratory infections: the impact of gut dysbiosis on secondary disease outcomes

Bacteria that colonize the human gastrointestinal tract are essential for good health. The gut microbiota has a critical role in pulmonary immunity and host’s defense against viral respiratory infections. The gut microbiota’s composition and function can be profoundly affected in many disease settin...

Descripción completa

Detalles Bibliográficos
Autores principales: Sencio, Valentin, Machado, Marina Gomes, Trottein, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835650/
https://www.ncbi.nlm.nih.gov/pubmed/33500564
http://dx.doi.org/10.1038/s41385-020-00361-8
_version_ 1783642574661091328
author Sencio, Valentin
Machado, Marina Gomes
Trottein, François
author_facet Sencio, Valentin
Machado, Marina Gomes
Trottein, François
author_sort Sencio, Valentin
collection PubMed
description Bacteria that colonize the human gastrointestinal tract are essential for good health. The gut microbiota has a critical role in pulmonary immunity and host’s defense against viral respiratory infections. The gut microbiota’s composition and function can be profoundly affected in many disease settings, including acute infections, and these changes can aggravate the severity of the disease. Here, we discuss mechanisms by which the gut microbiota arms the lung to control viral respiratory infections. We summarize the impact of viral respiratory infections on the gut microbiota and discuss the potential mechanisms leading to alterations of gut microbiota’s composition and functions. We also discuss the effects of gut microbial imbalance on disease outcomes, including gastrointestinal disorders and secondary bacterial infections. Lastly, we discuss the potential role of the lung–gut axis in coronavirus disease 2019.
format Online
Article
Text
id pubmed-7835650
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group US
record_format MEDLINE/PubMed
spelling pubmed-78356502021-01-26 The lung–gut axis during viral respiratory infections: the impact of gut dysbiosis on secondary disease outcomes Sencio, Valentin Machado, Marina Gomes Trottein, François Mucosal Immunol Review Article Bacteria that colonize the human gastrointestinal tract are essential for good health. The gut microbiota has a critical role in pulmonary immunity and host’s defense against viral respiratory infections. The gut microbiota’s composition and function can be profoundly affected in many disease settings, including acute infections, and these changes can aggravate the severity of the disease. Here, we discuss mechanisms by which the gut microbiota arms the lung to control viral respiratory infections. We summarize the impact of viral respiratory infections on the gut microbiota and discuss the potential mechanisms leading to alterations of gut microbiota’s composition and functions. We also discuss the effects of gut microbial imbalance on disease outcomes, including gastrointestinal disorders and secondary bacterial infections. Lastly, we discuss the potential role of the lung–gut axis in coronavirus disease 2019. Nature Publishing Group US 2021-01-26 2021 /pmc/articles/PMC7835650/ /pubmed/33500564 http://dx.doi.org/10.1038/s41385-020-00361-8 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Review Article
Sencio, Valentin
Machado, Marina Gomes
Trottein, François
The lung–gut axis during viral respiratory infections: the impact of gut dysbiosis on secondary disease outcomes
title The lung–gut axis during viral respiratory infections: the impact of gut dysbiosis on secondary disease outcomes
title_full The lung–gut axis during viral respiratory infections: the impact of gut dysbiosis on secondary disease outcomes
title_fullStr The lung–gut axis during viral respiratory infections: the impact of gut dysbiosis on secondary disease outcomes
title_full_unstemmed The lung–gut axis during viral respiratory infections: the impact of gut dysbiosis on secondary disease outcomes
title_short The lung–gut axis during viral respiratory infections: the impact of gut dysbiosis on secondary disease outcomes
title_sort lung–gut axis during viral respiratory infections: the impact of gut dysbiosis on secondary disease outcomes
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835650/
https://www.ncbi.nlm.nih.gov/pubmed/33500564
http://dx.doi.org/10.1038/s41385-020-00361-8
work_keys_str_mv AT senciovalentin thelunggutaxisduringviralrespiratoryinfectionstheimpactofgutdysbiosisonsecondarydiseaseoutcomes
AT machadomarinagomes thelunggutaxisduringviralrespiratoryinfectionstheimpactofgutdysbiosisonsecondarydiseaseoutcomes
AT trotteinfrancois thelunggutaxisduringviralrespiratoryinfectionstheimpactofgutdysbiosisonsecondarydiseaseoutcomes
AT senciovalentin lunggutaxisduringviralrespiratoryinfectionstheimpactofgutdysbiosisonsecondarydiseaseoutcomes
AT machadomarinagomes lunggutaxisduringviralrespiratoryinfectionstheimpactofgutdysbiosisonsecondarydiseaseoutcomes
AT trotteinfrancois lunggutaxisduringviralrespiratoryinfectionstheimpactofgutdysbiosisonsecondarydiseaseoutcomes